CTOs on the Move

Recovree

www.recovree.com

 
We help people find and maintain recovery from substance misuse through peer relationships. Recovree provides services to support the health and wellness of employees including on-demand access to recovery coaches with lived-experience, comprehensive chemical health assessments, and incident response planning. Employees struggling with drug and alcohol addiction can have a significant impact on a company`s productivity, safety and culture. Our services help employers retain top talent, improve the health and wellness of their teams and provide better access to resources for people who need help now. Check out our Recovery Friendly Workplace Toolkit, where we introduce you to the disease ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.recovree.com
  • 370 Wabasha Street N. Suite 500
    Staint Paul, MN USA 55102
  • Phone: 651.419.1719

Executives

Name Title Contact Details
Mike Milkovich
Chief Technology Officer Profile

Similar Companies

Downey Regional Medical Center

Downey Regional Medical Center, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Downey Regional Medical Center, Inc. is based in Downey, CA. You can find more information on Downey Regional Medical Center, Inc. at www.drmci.org

AFA Capital

AFA Capital is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.

Children's Respite Care Center Inc

Children's Respite Care Center Inc is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Visit us at www.drugs.com.